Summary:
Living with Type 1 Diabetes?
Consider the Gazelle Study
If you are an adult between ages 18 and 65 living with type 1 diabetes, you may be eligible to take part in the GAZELLE clinical research trial. This trial will look at an investigational fast-acting insulin to see if it works as effectively as an existing fast-acting insulin already being used to treat diabetes.
Qualified Participants Must:
• Be an adult between ages 18 and 65 living with type 1 diabetes
Qualified Participants May Receive:
Trial-related medications, procedures, equipment and supplies will be provided at no cost; health insurance is not required to participate.